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Accurate assessment of nodal involvement is essential inthe management of lung cancer. Recently, the Interna-
tional Association for the Study of Lung Cancer (IASLC)
Lung Cancer Staging Project published a new lymph node
map with the aim of creating an internationally agreed frame-
work that would allow precise and uniform determination of
lymph node status by centers around the globe.1 This new
map contains important changes to the previously used
Mountain-Dresler2 and Naruke3 maps.
Conformal radiotherapy planning requires accurate de-
lineation of target volumes. Although there is debate regard-
ing the merits of elective versus involved mediastinal nodal
irradiation,4–6 accurate outlining of nodal groups is essential
regardless for both prognostication and treatment delivery.
Nodal stations are usually outlined as contiguous volumes on
computed tomography (CT) scans of the chest, and this
generally requires complete and precise descriptions of the
anatomical limits to be outlined. Atlases have been created to
assist with this task and aim to provide comprehensive guides
regarding station boundaries (e.g., Chapet7). We feel that the
new IASLC map contains some ambiguities from the view-
point of radiotherapy planning and outline these here in the
hope of promoting discussion that clarifies how radiation
oncologists should implement the IASLC map.
Station 1
The upper limit of station 1 has now been defined as the
lower limit of the cricoid cartilage. The lower border is the
clavicles bilaterally (the definition does not specify superior
or inferior clavicle) and the upper border is the manubrium
centrally. While the upper border of station 2 in midline is
also the upper border of the manubrium, the lateral borders of
stations 2 and 3 are the apex of lung and pleural space. The
location of the clavicle laterally varies depending on shoulder
position and creates variability in outlines based on this
border. In addition, the relative location of clavicle and lung
apex are also variable leading to potential uncertainty as to
the relative borders between stations 1, 2, and 3 (Figure 1).
As this is a distinction between N2 and N3 disease, clarity in
this definition is important.
Station 2
The inferior border of 2R is now the intersection of the
caudal margin of the innominate vein with the trachea. As has
been pointed out by Ichimura et al.,8 this is usually an oblique
intersection and raised questions as how best to represent this
on CT. For the purposes of completeness, we note the
clarification by Rusch in reply8 that CT-based outlines should
follow the caudal margin precisely (and therefore obliquely
when required).
Station 3
Like the problem of the junction of station 1 and 2, the
inferior and superior lateral limits of stations 1 and 3 are the
clavicles and apex of chest, respectively. There is no specific
definition of the upper limit of level 3 in the midline, although
for 3a it would presumably be intended to match the lower
midline limit of station 1 at the upper manubrium.
Station 4
Previously, the lower border of 4R was defined as a
horizontal line extending across the right main bronchus at
the upper margin of the origin of the upper lobe bronchus. It
is now at the lower border of the azygos vein where it meets
the superior vena cava. In theory, this now joins below with
station 10 laterally (which ends superiorly at the same point).
However, as station 10 is restricted to nodes immediately
adjacent to proximal portions of mainstem bronchi and hilar
vessels, there may be potential for confusion for nodes
located below 4R but not clearly fitting the definition of
station 10, especially the region immediately in front of the
tracheal bifurcation. Is it the intent to classify such centrally
located nodes as N1? (Figure 2).
Previously, the lower border of 4L was defined as a
horizontal line extending across the left main bronchus at the
upper margin of the origin of the upper lobe bronchus. It is
now the upper rim of the left main pulmonary artery. Like the
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right side, this matches the upper border of station 10 on that
side but potentially expands the reach of station 10L superi-
orly and anteriorly (Figure 2).
Any ambiguity between the junctions of stations 10 and
4 is particularly important given that they are N1 and N2
stations, respectively.
Station 5
Station 5 commences lower than 4L at the lower border of
the aortic arch and ends inferiorly at the same level based on the
upper rim of the left main pulmonary artery. Along this course,
it sits lateral to 4L using the ligamentum arteriosum to separate
the two stations. However, the ligamentum arteriosum is not
always seen on CT scans,9 introducing potential uncertainty in
those patients whose staging is clinical rather surgical.
Station 6
Station 6 is defined as covering nodes anterior and
lateral to the ascending aorta and aortic arch. However, the
lower border is now defined as level with the lower border of
the aortic arch, which will limit coverage of the ascending
aorta. The lower border of station 6 now junctions with the
upper border of station 5, so there should be no overlap
between these two stations. The IASLC node map document
appears ambiguous on this point as the diagrammatic repre-
sentation of station 6 overlaps with station 5 by extending
below the lower border of the aortic arch on the axial CT
view but not the sagittal view (Figures 4B,E in the article by
Rusch et al.1).
Station 7
One of the major changes of the IASLC node map is the
enlargement of station 7. Although the lower border defini-
tions have been altered to the upper border of the lower lobe
bronchus on the left and the lower border of the bronchus
intermedius on the right, the basis of the expansion is two-
fold. First, the inferior borders of 4R and 4L have moved
superiorly. Second, the upper limit of station 8 now matches
the lower limit of station 7. Thus, station 7 extends further
anteriorly and posteriorly than before (Figure 3).
FIGURE 1. Axial computed tomography section through
root of neck/upper chest. Vessels and organs are outlined.
Stations 1 and 3 are shown with potential for overlap
highlighted.
FIGURE 2. Axial computed tomography section through
chest just below upper left main pulmonary artery and azy-
gos vein. Stations 10 L and R are shown highlighting superior/
anterior extension beyond close proximity to right and left
main bronchi.
FIGURE 3. Axial computed tomography section below
carina showing anterior and posterior extension of station 7.
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Stations 8 and 9
The superior and inferior extent of station 8 is now
clearly defined. Along the length of this station, the limit is
defined as nodes adjacent to the esophagus. This could
create some uncertainty when using CT-based outlining in
determining a consistent border to separate station 8 with
nodes of station 9 that sit more laterally within the pul-
monary ligament.
Stations 10 and 11
As discussed previously, station 10 now extends further
medially toward the carina. The implication of this change is
that N1 regions extend further than previously. The merit of
such a change had been discussed previously,10 but certainly
the change is worth highlighting.
CT-based separation of station 10 and 11 can be chal-
lenging. Given the clinical uncertainty of this separation, it is
not clear whether maintaining station 11 separate from station
10 has merit and CT outlining atlases often merge these
stations.7
CONCLUSION
The IASLC node map is a valuable addition to the
staging of lung cancer and aims to create a reliable and
reproducible guide. The Staging Committee is to be com-
mended for its efforts in this endeavor. Our aim in this
critique is to promote discussion that may help resolve
potential ambiguities in CT-based outlining of the mediasti-
num based on the new IASLC map. Variation in outlining
treatment target volumes is a known issue for radiation
oncologists,11–13 and we hope that clarification of the points
we have raised may assist both CT-based staging and radio-
therapy treatment planning.
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